Velcade and Human chorionic gonadotropin increased - a phase IV clinical study of FDA data

Summary:

Human chorionic gonadotropin increased is reported as a side effect among people who take Velcade (bortezomib), especially for people who are female, 40-49 old, also take Revlimid, and have Nausea.

The phase IV clinical study analyzes which people have Human chorionic gonadotropin increased when taking Velcade. It is created by eHealthMe based on reports of 66,250 people who have side effects when taking Velcade from the FDA, and is updated regularly.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.

What is Human chorionic gonadotropin increased?

Human chorionic gonadotropin increased is found to be associated with 59 drugs and 131 conditions by eHealthMe. Check the latest studies of Human chorionic gonadotropin increased.

On Jul, 18, 2026

66,250 people reported to have side effects when taking Velcade.
Among them, 23 people (0.03%) have Human chorionic gonadotropin increased.

Could Velcade cause Human chorionic gonadotropin increased?

Among these 23 people:

What is the gender of people who have Human chorionic gonadotropin increased when taking Velcade? *

female: 100 %
male: 0.0 %

What is the age of people who have Human chorionic gonadotropin increased when taking Velcade? *

What are other drugs people take besides Velcade? *

What are other side effects people have besides Human chorionic gonadotropin increased? *

Uterine Haemorrhage (uterine bleeding): 3 people, 13.04%
Infusion Related Reaction: 1 person, 4.35%
Blood Disorder: 1 person, 4.35%
Dehydration (dryness resulting from the removal of water): 1 person, 4.35%
Drug Specific Antibody Present: 1 person, 4.35%
Fever: 1 person, 4.35%
Headache (pain in head): 1 person, 4.35%
Hereditary Angioedema (recurrent episodes of severe swelling): 1 person, 4.35%
Hypotension (abnormally low blood pressure): 1 person, 4.35%
Lymphatic Disorder (disease of lymphatic system): 1 person, 4.35%

What are the existing conditions these people have? *

Herpes Zoster: 2 people, 8.70%
Nausea (feeling of having an urge to vomit): 2 people, 8.70%
Hereditary Angioedema (recurrent episodes of severe swelling): 1 person, 4.35%
Amyloidosis (a tumour within which amyloid is produced): 1 person, 4.35%
Birth Control: 1 person, 4.35%
Bone Loss: 1 person, 4.35%
Depression: 1 person, 4.35%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 1 person, 4.35%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.35%
Gastric Ulcer (stomach ulcer): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Velcade and have Human chorionic gonadotropin increased?

- Check whether Human chorionic gonadotropin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Velcade:

Velcade (66,422 reports)

Human chorionic gonadotropin increased treatments and more:

Human chorionic gonadotropin increased (1,249 reports)

How severe was Human chorionic gonadotropin increased and when was it recovered:

Human chorionic gonadotropin increased in Velcade

Expand to all the drugs that have ingredients of bortezomib:

Human chorionic gonadotropin increased and drugs with ingredients of bortezomib

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Human chorionic gonadotropin increased:

Human chorionic gonadotropin increased (59 drugs)

Browse all the conditions that are associated with Human chorionic gonadotropin increased:

Human chorionic gonadotropin increased (131 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib (the active ingredients of Velcade) and Velcade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.